Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 208

1.

Pulmonary function patterns and their association with genotype and phenotype in adult cystic fibrosis patients.

Stylemans D, Verbanck S, Vincken S, Vincken W, De Wachter E, Vanderhelst E.

Acta Clin Belg. 2018 Oct 12:1-7. doi: 10.1080/17843286.2018.1533716. [Epub ahead of print]

PMID:
30311545
2.

Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice.

Cataldo D, Derom E, Liistro G, Marchand E, Ninane V, Peché R, Slabbynck H, Vincken W, Janssens W.

Int J Chron Obstruct Pulmon Dis. 2018 Jul 5;13:2089-2099. doi: 10.2147/COPD.S164259. eCollection 2018. Review.

3.

Spacer devices for inhaled therapy: why use them, and how?

Vincken W, Levy ML, Scullion J, Usmani OS, Dekhuijzen PNR, Corrigan CJ.

ERJ Open Res. 2018 Jun 18;4(2). pii: 00065-2018. doi: 10.1183/23120541.00065-2018. eCollection 2018 Apr. Review.

4.

The quantitative link of lung clearance index to bronchial segments affected by bronchiectasis.

Verbanck S, King GG, Zhou W, Miller A, Thamrin C, Schuermans D, Ilsen B, Ernst CW, de Mey J, Vincken W, Vanderhelst E.

Thorax. 2018 Jan;73(1):82-84. doi: 10.1136/thoraxjnl-2017-210496. Epub 2017 Sep 2.

PMID:
28866642
5.

Inhaled treatment of COPD: a Delphi consensus statement.

Ninane V, Corhay JL, Germonpré P, Janssens W, Joos GF, Liistro G, Vincken W, Gurdain S, Vanvlasselaer E, Lehouck A.

Int J Chron Obstruct Pulmon Dis. 2017 Mar 6;12:793-801. doi: 10.2147/COPD.S125564. eCollection 2017.

6.

A Belgian survey on the diagnosis of asthma-COPD overlap syndrome.

Cataldo D, Corhay JL, Derom E, Louis R, Marchand E, Michils A, Ninane V, Peché R, Pilette C, Vincken W, Janssens W.

Int J Chron Obstruct Pulmon Dis. 2017 Feb 13;12:601-613. doi: 10.2147/COPD.S124459. eCollection 2017.

7.
8.

A rare presentation of histologically proven sarcoidosis of the knee: A case report and brief review of the literature.

Deschuyteneer E, Rongé R, Riffi A, De Pierre K, Vandenbroucke F, Boulet C, Goossens A, Vincken W.

Acta Clin Belg. 2017 Jun;72(3):210-212. doi: 10.1080/17843286.2016.1235243. Epub 2016 Sep 23. Review.

PMID:
27663033
9.

Inhaled Aerosol Distribution in Human Airways: A Scintigraphy-Guided Study in a 3D Printed Model.

Verbanck S, Ghorbaniasl G, Biddiscombe MF, Dragojlovic D, Ricks N, Lacor C, Ilsen B, de Mey J, Schuermans D, Underwood SR, Barnes PJ, Vincken W, Usmani OS.

J Aerosol Med Pulm Drug Deliv. 2016 Dec;29(6):525-533. Epub 2016 Jun 23.

10.

Mild Lung Restriction in Breast Cancer Patients After Hypofractionated and Conventional Radiation Therapy: A 3-Year Follow-Up.

Verbanck S, Hanon S, Schuermans D, Van Parijs H, Vinh-Hung V, Miedema G, Verellen D, Storme G, Fontaine C, Lamote J, De Ridder M, Vincken W.

Int J Radiat Oncol Biol Phys. 2016 Jul 1;95(3):937-945. doi: 10.1016/j.ijrobp.2016.02.008. Epub 2016 Feb 6.

PMID:
27302510
11.

Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT).

Levy ML, Dekhuijzen PN, Barnes PJ, Broeders M, Corrigan CJ, Chawes BL, Corbetta L, Dubus JC, Hausen T, Lavorini F, Roche N, Sanchis J, Usmani OS, Viejo J, Vincken W, Voshaar T, Crompton GK, Pedersen S.

NPJ Prim Care Respir Med. 2016 Apr 21;26:16017. doi: 10.1038/npjpcrm.2016.17. Review.

12.

Transfer factor, lung volumes, resistance and ventilation distribution in healthy adults.

Verbanck S, Van Muylem A, Schuermans D, Bautmans I, Thompson B, Vincken W.

Eur Respir J. 2016 Jan;47(1):166-76. doi: 10.1183/13993003.00695-2015. Epub 2015 Nov 19.

13.

New developments in inhaler devices within pharmaceutical companies: A systematic review of the impact on clinical outcomes and patient preferences.

Ninane V, Vandevoorde J, Cataldo D, Derom E, Liistro G, Munghen E, Peché R, Schlesser M, Verleden G, Vincken W.

Respir Med. 2015 Nov;109(11):1430-8. doi: 10.1016/j.rmed.2015.09.013. Epub 2015 Sep 30. Review.

14.

Increase in ventilated air spaces after eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients.

Vanderhelst E, De Wachter E, Willekens J, Schuermans D, Vincken W, Malfroot A, Verbanck S.

Acta Clin Belg. 2015 Feb;70(1):30-3. doi: 10.1179/2295333714Y.0000000079. Epub 2014 Sep 24.

PMID:
25253536
15.

Occupational asthma due to colophony in a violin player.

Hanon S, Rongé R, Potvin M, Schuermans D, Vincken W.

J Allergy Clin Immunol Pract. 2014 Sep-Oct;2(5):624-5. doi: 10.1016/j.jaip.2014.06.018. No abstract available.

PMID:
25213061
16.

Irreversible acinar airway abnormality in well controlled asthma.

Hanon S, Schuermans D, Vincken W, Verbanck S.

Respir Med. 2014 Nov;108(11):1601-7. doi: 10.1016/j.rmed.2014.07.019. Epub 2014 Aug 19.

17.

The Lung Clearance Index as a probe for the effectiveness of short-term therapies in cystic fibrosis lung disease.

Vanderhelst E, De Meirleir L, Schuermans D, Malfroot A, Vincken W, Verbanck S.

J Cyst Fibros. 2015 Mar;14(2):285-6. doi: 10.1016/j.jcf.2014.08.004. Epub 2014 Aug 28. No abstract available.

18.

Evidence of an acinar response following treatment for exacerbation in adult patients with cystic fibrosis.

Vanderhelst E, De Meirleir L, Schuermans D, Malfroot A, Vincken W, Verbanck S.

Respiration. 2014;87(6):492-8. doi: 10.1159/000360772. Epub 2014 May 8.

19.

Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 study.

Vincken W, Aumann J, Chen H, Henley M, McBryan D, Goyal P.

Int J Chron Obstruct Pulmon Dis. 2014 Feb 24;9:215-28. doi: 10.2147/COPD.S51592. eCollection 2014.

20.

COPD awareness survey: do Belgian pulmonary physicians comply with the GOLD guidelines 2010?

Decramer M, Brusselle G, Buffels J, Corhay JL, De Backer W, Degryse JM, Janssens W, Marchand E, Van den Brande P, Vincken W, Gayan-Ramirez G, Van Craenendonck V, Vandenberghe H, De Vuyst P; COPD Working Group.

Acta Clin Belg. 2013 Sep-Oct;68(5):325-40.

PMID:
24579239
21.

Severe right heart failure in a patient with chronic obstructive lung disease: a diagnostic challenge.

Meysman M, Pipeleers-Marichal M, Geers C, Ilsen B, Vincken W.

Indian J Chest Dis Allied Sci. 2013 Jul-Sep;55(3):159-62.

PMID:
24380224
22.

Usage of inhalation devices in asthma and chronic obstructive pulmonary disease: a Delphi consensus statement.

Ninane V, Brusselle GG, Louis R, Dupont L, Liistro G, De Backer W, Schlesser M, Vincken W.

Expert Opin Drug Deliv. 2014 Mar;11(3):313-23. doi: 10.1517/17425247.2014.872626. Epub 2013 Dec 18.

23.

Chronic bronchitis in COPD patients is associated with increased risk of exacerbations: a cross-sectional multicentre study.

Corhay JL, Vincken W, Schlesser M, Bossuyt P, Imschoot J.

Int J Clin Pract. 2013 Dec;67(12):1294-301. doi: 10.1111/ijcp.12248.

PMID:
24246208
24.

Prescription of inhalers in asthma and COPD: towards a rational, rapid and effective approach.

Dekhuijzen PN, Vincken W, Virchow JC, Roche N, Agusti A, Lavorini F, van Aalderen WM, Price D.

Respir Med. 2013 Dec;107(12):1817-21. doi: 10.1016/j.rmed.2013.09.013. Epub 2013 Sep 25. Review.

25.

Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of 11 patients.

Vanderhelst E, De Wachter E, Willekens J, Piérard D, Vincken W, Malfroot A.

J Cyst Fibros. 2013 Dec;12(6):662-6. doi: 10.1016/j.jcf.2013.04.009. Epub 2013 May 21.

26.

Acinar and conductive ventilation heterogeneity in severe CF lung disease: back to the model.

Verbanck S, Paiva M, Schuermans D, Malfroot A, Vincken W, Vanderhelst E.

Respir Physiol Neurobiol. 2013 Aug 15;188(2):124-32. doi: 10.1016/j.resp.2013.05.011. Epub 2013 May 18.

PMID:
23692927
27.

Lung clearance index in adult cystic fibrosis patients: the role of convection-dependent lung units.

Verbanck S, Paiva M, Paeps E, Schuermans D, Malfroot A, Vincken W, Vanderhelst E.

Eur Respir J. 2013 Aug;42(2):380-8. doi: 10.1183/09031936.00125312. Epub 2012 Oct 25.

28.

Air leaks localized with lung ventilation SPECT.

Ceulemans G, De Meirleir L, Keyaerts M, Smets D, Verdries D, Vincken W, Everaert H.

Clin Nucl Med. 2012 Dec;37(12):1182-3. doi: 10.1097/RLU.0b013e318263909a.

PMID:
22996237
29.

Reply to 'Methicillin-resistant Staphylococcus aureus'.

Vanderhelst E, De Meirleir L, Verbanck S, Piérard D, Vincken W, Malfroot A.

J Cyst Fibros. 2013 Mar;12(2):183. doi: 10.1016/j.jcf.2012.08.002. Epub 2012 Aug 29. No abstract available.

30.

Small airways function in breast cancer patients before and after radiotherapy.

Verbanck S, Hanon S, Schuermans D, Van Parijs H, Vinh-Hung V, Miedema G, Verellen D, Storme G, Vanhoeij M, Lamote J, De Ridder M, Vincken W.

Breast Cancer Res Treat. 2012 Oct;135(3):857-65. doi: 10.1007/s10549-012-2201-7. Epub 2012 Aug 22.

PMID:
22910929
31.

Evidence of improved small airways function after azithromycin treatment in diffuse panbronchiolitis.

Hanon S, Verbanck S, Schuermans D, Vanden Berghe B, Vanderhelst E, Vincken W.

Respiration. 2012;84(1):75-9. doi: 10.1159/000339404. Epub 2012 Jun 29.

32.

An incident case of primary acquired pulmonary alveolar proteinosis.

Vanderhelst E, Bonella F, Wissing K, Verfaillie G, Geers C, Vincken W.

Acta Clin Belg. 2012 Mar-Apr;67(2):135-6.

PMID:
22712171
33.

Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial.

Van Parijs H, Miedema G, Vinh-Hung V, Verbanck S, Adriaenssens N, Kerkhove D, Reynders T, Schuermans D, Leysen K, Hanon S, Van Camp G, Vincken W, Storme G, Verellen D, De Ridder M.

Radiat Oncol. 2012 Jun 1;7:80. doi: 10.1186/1748-717X-7-80.

34.

Whole-lung lavage: a successful treatment for restoring acinar ventilation distribution in primary acquired pulmonary alveolar proteinosis.

Vanderhelst E, Hanon S, Verbanck S, Schuermans D, Wissing K, Bonella F, Vincken W.

Respiration. 2012;84(1):70-4. doi: 10.1159/000338980. Epub 2012 May 23.

35.

Bronchial and alveolar components of exhaled nitric oxide and their relationship.

Verbanck S, Malinovschi A, George S, Gelb AF, Vincken W, Van Muylem A.

Eur Respir J. 2012 May;39(5):1258-61. doi: 10.1183/09031936.00105611. No abstract available.

36.

Ventilation heterogeneity in the acinar and conductive zones of the normal ageing lung.

Verbanck S, Thompson BR, Schuermans D, Kalsi H, Biddiscombe M, Stuart-Andrews C, Hanon S, Van Muylem A, Paiva M, Vincken W, Usmani O.

Thorax. 2012 Sep;67(9):789-95. doi: 10.1136/thoraxjnl-2011-201484. Epub 2012 Apr 27.

37.

Spontaneous soccer-induced pneumomediastinum in a 39-year-old man.

De Smet K, Ilsen B, De Mey J, De Maeseneer M, Vincken W.

JBR-BTR. 2011 Nov-Dec;94(6):346-7.

PMID:
22338392
38.

Relationships between the lung clearance index and conductive and acinar ventilation heterogeneity.

Verbanck S, Paiva M, Schuermans D, Hanon S, Vincken W, Van Muylem A.

J Appl Physiol (1985). 2012 Mar;112(5):782-90. doi: 10.1152/japplphysiol.01221.2011. Epub 2011 Dec 8.

39.

Quality of life and patient satisfaction after video-assisted thoracic sympathicolysis for essential hyperhidrosis: a follow-up of 138 patients.

Vanderhelst E, De Keukeleire T, Verbanck S, Vincken W, Noppen M.

J Laparoendosc Adv Surg Tech A. 2011 Dec;21(10):905-9. doi: 10.1089/lap.2011.0258. Epub 2011 Oct 19.

PMID:
22011277
40.

Prevalence and impact on FEV(1) decline of chronic methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients with cystic fibrosis. A single-center, case control study of 165 patients.

Vanderhelst E, De Meirleir L, Verbanck S, Piérard D, Vincken W, Malfroot A.

J Cyst Fibros. 2012 Jan;11(1):2-7. doi: 10.1016/j.jcf.2011.08.006. Epub 2011 Sep 9.

41.

The ADMIT series--Issues in Inhalation Therapy. 7. Ways to improve pharmacological management of COPD: the importance of inhaler choice and inhalation technique.

Broeders ME, Vincken W, Corbetta L; ADMIT Working Group.

Prim Care Respir J. 2011 Sep;20(3):338-43. doi: 10.4104/pcrj.2011.00062.

42.

Internal consistency of reference equations.

Verbanck S, Vandevoorde J, Vincken W.

Eur Respir J. 2011 Jul;38(1):233-4; author reply 234-5. doi: 10.1183/09031936.00022411. No abstract available.

43.

Effect of indacaterol on exercise endurance and lung hyperinflation in COPD.

O'Donnell DE, Casaburi R, Vincken W, Puente-Maestu L, Swales J, Lawrence D, Kramer B; INABLE 1 study group.

Respir Med. 2011 Jul;105(7):1030-6. doi: 10.1016/j.rmed.2011.03.014. Epub 2011 Apr 16.

44.

Retail sales of inhalation devices in European countries: so much for a global policy.

Lavorini F, Corrigan CJ, Barnes PJ, Dekhuijzen PR, Levy ML, Pedersen S, Roche N, Vincken W, Crompton GK; Aerosol Drug Management Improvement Team.

Respir Med. 2011 Jul;105(7):1099-103. doi: 10.1016/j.rmed.2011.03.012. Epub 2011 Apr 13.

45.

Nocardia asiatica visiting Belgium: nocardiosis in a immunocompetent patient.

Verfaillie L, De Regt J, De Bel A, Vincken W.

Acta Clin Belg. 2010 Nov-Dec;65(6):425-7.

PMID:
21268959
46.

Is there any relationship between nCPAP therapy and signs of sinus hyperpneumatization?

De Weerdt S, Haentjens P, Van Binst AM, Baron I, Clement P, Vincken W.

B-ENT. 2010;6(3):171-5.

PMID:
21090158
47.

Detecting upper airway obstruction in patients with tracheal stenosis.

Verbanck S, de Keukeleire T, Schuermans D, Meysman M, Vincken W, Thompson B.

J Appl Physiol (1985). 2010 Jul;109(1):47-52. doi: 10.1152/japplphysiol.01103.2009. Epub 2010 May 13.

48.

The impact of concomitant rhinitis on asthma-related quality of life and asthma control.

Vandenplas O, Dramaix M, Joos G, Louis R, Michils A, Verleden G, Vincken W, Vints AM, Herbots E, Bachert C.

Allergy. 2010 Oct;65(10):1290-7. doi: 10.1111/j.1398-9995.2010.02365.x. Epub 2010 Apr 7.

49.

Inflammation and airway function in the lung periphery of patients with stable asthma.

Verbanck S, Schuermans D, Vincken W.

J Allergy Clin Immunol. 2010 Mar;125(3):611-6. doi: 10.1016/j.jaci.2009.10.053. Epub 2010 Feb 4.

PMID:
20132975
50.

The ADMIT series - Issues in inhalation therapy. 4) How to choose inhaler devices for the treatment of COPD.

Vincken W, Dekhuijzen PR, Barnes P; ADMIT Group.

Prim Care Respir J. 2010 Mar;19(1):10-20. doi: 10.4104/pcrj.2009.00062. Review.

Supplemental Content

Loading ...
Support Center